Shandong Pharmaceutical Glass Co.Ltd (SHA:600529)
China flag China · Delayed Price · Currency is CNY
18.53
-0.01 (-0.05%)
Sep 14, 2026, 3:00 PM CST

SHA:600529 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
4,4584,4144,8454,9374,1303,820
Other Revenue
46.360.0159.5645.6856.8255.53
4,5044,4744,9054,9824,1873,875
Revenue Growth
-1.42%-8.79%-1.55%18.98%8.05%13.08%
Cost of Revenue
3,1053,0883,3393,6183,0902,789
Gross Profit
1,3991,3861,5661,3641,0981,086
Selling, General & Admin
332.26338.72341.62332.17251.59230.19
Research & Development
154.1174.8151.76137.95138.94135.63
Other Operating Expenses
57.3143.239.0633.8432.0331.19
Operating Expenses
537.19552.14534.56515.37434.56407.88
Operating Income
862.2833.671,031848.58662.95678.38
Interest Expense
-1.1-0.51-0.03-0.23-0.26-0.28
Interest & Investment Income
35.4733.1135.7744.1116.7417.47
Currency Exchange Gain (Loss)
-21.524.2817.2213.0131.5-9.48
Other Non Operating Income (Expenses)
-0.62-3.71-2.36-2.8-0.2-2.44
EBT Excluding Unusual Items
874.43866.841,082902.67710.73683.64
Gain (Loss) on Sale of Investments
7.079.1424.4622.833.739.26
Gain (Loss) on Sale of Assets
-5.36-4.3-1.33-12.24-3.51-22.7
Asset Writedown
-53.79-53.79-5.09-12.88-16.96-11.61
Other Unusual Items
19.2812.9510.7410.4414.0630.13
Pretax Income
841.64830.831,111910.82708.05688.72
Income Tax Expense
152.28141.2167.81135.0289.7697.63
Earnings From Continuing Operations
689.35689.63942.99775.8618.29591.09
Net Income
689.35689.63942.99775.8618.29591.09
Net Income to Common
689.35689.63942.99775.8618.29591.09
Net Income Growth
-17.83%-26.87%21.55%25.48%4.60%4.72%
Shares Outstanding (Basic)
663663664663600597
Shares Outstanding (Diluted)
663663664663600597
Shares Change
-0.14%-0.15%0.15%10.46%0.54%0.49%
EPS (Basic)
1.041.041.421.171.030.99
EPS (Diluted)
1.041.041.421.171.030.99
EPS Growth
-17.71%-26.76%21.37%13.59%4.04%4.21%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
422.91345.06517.27376.45-458.27-58.82
Free Cash Flow Per Share
0.640.520.780.57-0.76-0.10
Dividend Per Share
0.4800.4600.6200.4000.3000.300
Dividend Growth
-20.00%-25.81%55.00%33.33%0%0%
Gross Margin
31.07%30.98%31.93%27.38%26.21%28.03%
Operating Margin
19.14%18.63%21.03%17.03%15.83%17.51%
Profit Margin
15.30%15.41%19.23%15.57%14.77%15.25%
Free Cash Flow Margin
9.39%7.71%10.55%7.56%-10.94%-1.52%
EBITDA
1,2431,2231,4171,174958.13919.03
EBITDA Margin
27.60%27.33%28.88%23.56%22.88%23.71%
D&A For EBITDA
381.14389.26385.15325.13295.17240.64
EBIT
862.2833.671,031848.58662.95678.38
EBIT Margin
19.14%18.63%21.03%17.03%15.83%17.51%
Effective Tax Rate
18.09%16.99%15.11%14.82%12.68%14.17%
Revenue as Reported
4,5044,4744,9054,9824,1873,875